FGF23 deficiency ameliorates progression of chronic kidney disease in mice.

被引:0
|
作者
Andrukhova, Olena [1 ]
Slavic, Svetlana [2 ]
Murali, Sathish Kumar [2 ]
Erben, Reinhold [3 ]
机构
[1] Inst Physiol Pathophysiol & Biophysics, Vienna, Austria
[2] Univ Vet Med, Biomed Sci 1Dept, Vienna, Austria
[3] Univ Vet Med, Vienna, Austria
关键词
D O I
暂无
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
MO0134
引用
收藏
页码:S390 / S390
页数:1
相关论文
共 50 条
  • [1] FGF23 IN CHRONIC KIDNEY DISEASE
    Wahl, Patricia
    Wolf, Myles
    ENDOCRINE FGFS AND KLOTHOS, 2012, 728 : 107 - 125
  • [2] FGF23 and Klotho in chronic kidney disease
    Olauson, Hannes
    Larsson, Tobias E.
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2013, 22 (04): : 397 - 404
  • [3] CTERMINAL FGF23 VERSUS INTACT FGF23 AS CARDIOVASCULAR PREDICTOR IN CHRONIC KIDNEY DISEASE
    Schauerte, Johanna
    Emrich, Insa
    Seiler-Mussler, Sarah
    Fliser, Danilo
    Heine, Gunnar
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2017, 32 : 68 - +
  • [4] Myeloperoxidase deficiency ameliorates progression of chronic kidney disease in mice
    Lehners, Alexander
    Lange, Sascha
    Niemann, Gianina
    Rosendahl, Alva
    Meyer-Schwesinger, Catherine
    Oh, Jun
    Stahl, Rolf
    Ehmke, Heimo
    Benndorf, Ralf
    Klinke, Anna
    Baldus, Stephan
    Wenzel, Ulrich Otto
    AMERICAN JOURNAL OF PHYSIOLOGY-RENAL PHYSIOLOGY, 2014, 307 (04) : F407 - F417
  • [5] Regulation and Effects of FGF23 in Chronic Kidney Disease
    Musgrove, John
    Wolf, Myles
    ANNUAL REVIEW OF PHYSIOLOGY, VOL 82, 2020, 82 : 365 - 390
  • [6] FGF23 and the PTH response to paricalcitol in chronic kidney disease
    D'Arrigo, Graziella
    Pizzini, Patrizia
    Cutrupi, Sebastiano
    Tripepi, Rocco
    Tripepi, Giovanni
    Mallamaci, Francesca
    Zoccali, Carmine
    EUROPEAN JOURNAL OF CLINICAL INVESTIGATION, 2020, 50 (02)
  • [7] FGF23 in Chronic Kidney Disease: Bridging the Heart and Anemia
    Figurek, Andreja
    Rroji, Merita
    Spasovski, Goce
    CELLS, 2023, 12 (04)
  • [8] FGF23 in chronic kidney disease: are we lost in translation?
    Bacchetta, Justine
    BONEKEY REPORTS, 2016, 5
  • [9] Effect of Niacin on FGF23 Concentration in Chronic Kidney Disease
    Rao, Madhumathi
    Steffes, Michael
    Bostom, Andrew
    Ix, Joachim H.
    AMERICAN JOURNAL OF NEPHROLOGY, 2014, 39 (06) : 484 - 490
  • [10] Estrogens and bone disease in chronic kidney disease: role of FGF23
    Cannata-Andia, Jorge B.
    Carrillo-Lopez, Natalia
    Naves-Diaz, Manuel
    CURRENT OPINION IN NEPHROLOGY AND HYPERTENSION, 2010, 19 (04): : 354 - 358